ARHGEF3, variants, traits, and what the research shows

ARHGEF3 - what this gene does

ARHGEF3 has 169 catalogued variants whose trait associations span three broad themes: liver-related conditions, immune function, and neurological traits. The data available here does not include detailed mechanistic descriptions, so the gene's role is characterized here solely by the trait domains its variants are linked to.

Key takeaways

• This gene carries variants associated with liver, immune, and neurological trait categories
• The three highest-magnitude variants each map to a different trait domain
• 169 variants are on file, including 21 with prior research summaries
• These signals come from GWAS (genome-wide association studies - large scans of many people's genomes for variants statistically linked to a trait), not diagnostic tests
• Specific effect sizes and replication details are not available in the current dataset for most variants

Notable variants

The three highest-magnitude entries are rs11918968, linked to a liver-related trait (magnitude 4.50); rs2062583, linked to an immune trait (magnitude 4.50); and rs73088024, linked to a neurological trait (magnitude 4.50). A group of lower-magnitude variants - including rs148484521, rs200666323, rs201843696, and rs201007278 - are also catalogued at magnitude 3.00, though specific trait annotations for these are not available in this dataset.

Trait associations

Three trait domains emerge from the highest-confidence entries. A liver-related association is carried by rs11918968. An immune-function signal is represented by rs2062583. A neurological association is anchored by rs73088024. Each top-tier variant points to a distinct domain; whether these reflect independent biological roles or a shared upstream pathway is not determinable from the available data.

Evidence quality

The three highest-magnitude variants - rs11918968, rs2062583, and rs73088024 - each score 4.50, the top tier in this dataset, suggesting stronger or better-replicated GWAS signals relative to the remaining catalogued entries. The bulk of the 169 variants sit at magnitude 3.00, and specific effect sizes, sample sizes, or replication cohort details are not available in the current summary data. Until more detailed effect-size and replication information is published, findings from this gene should be treated as preliminary.

What this is NOT

These variants are population-level statistical associations, not deterministic predictors of any health outcome for any individual. Nothing here constitutes medical advice, a diagnosis, or a recommendation to take any action.